Case studies: the impact of nonanalyte components on LC-MS/MS-based bioanalysis: strategies for identifying and overcoming matrix effects.
Achieving sufficient selectivity in bioanalysis is critical to ensure accurate quantitation of drugs and metabolites in biological matrices. Matrix effects most classically refer to modification of ionization efficiency of an analyte in the presence of matrix components. However, nonanalyte or matrix components present in samples can adversely impact the performance of a bioanalytical method and are broadly considered as matrix effects. For the current manuscript, we expand the scope to include matrix elements that contribute to isobaric interference and measurement bias. These three categories of matrix effects are illustrated with real examples encountered. The causes, symptoms, and suggested strategies and resolutions for each form of matrix effects are discussed. Each case is presented in the format of situation/action/result to facilitate reading.
Covance Laboratories, Inc., Bioanalytical Chemistry, Madison, WI 53704, USA.
Fumin
F
Li
Matthew
M
Ewles
Mary
M
Pelzer
Theodore
T
Brus
Aaron
A
Ledvina
Nicholas
N
Gray
Mohammad
M
Koupaei-Abyazani
Michael
M
Blackburn
D000818:Animals; D002138:Calibration; D002851:Chromatography, High Pressure Liquid / Q000592:standards; D004285:Dogs; D006801:Humans; D007553:Isotope Labeling; D051379:Mice; D004364:Pharmaceutical Preparations / Q000097:blood* / Q000378:metabolism / Q000652:urine; D010743:Phospholipids / Q000737:chemistry; D011092:Polyethylene Glycols / Q000737:chemistry; D011786:Quality Control; D011817:Rabbits; D051381:Rats; D053719:Tandem Mass Spectrometry / Q000592:standards
D004364:Pharmaceutical Preparations; D010743:Phospholipids; D011092:Polyethylene Glycols